Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

FDA Drug Recalls

11,818 recalls · Class II, newest first

Class II · Moderate risk

DermOtic Oil

Presence of Foreign Substance: Potential for broken glass within the glass pipette of the dropper.

Terminated Particulate / foreign matter Hill Dermaceuticals, Inc. NDC 68791-103-20 D-0637-2021
Class II · Moderate risk

Advance Hand Sanitizer

CGMP Deviations: Other lots and products of hand sanitizer recalled because they were manufactured under the same conditions as the product lots found to contain methanol.

Terminated Chemical / undeclared Dibar Nutricional S De Rl De Cv D-0647-2021
Class II · Moderate risk

ProtectoRx

CGMP Deviations: Other lots and products of hand sanitizer recalled because they were manufactured under the same conditions as the product lots found to contain methanol.

Terminated Chemical / undeclared Dibar Nutricional S De Rl De Cv NDC 75408-002-01 D-0646-2021
Class II · Moderate risk

DiBAR LABS Hand Sanitizer

CGMP Deviations: Other lots and products of hand sanitizer recalled because they were manufactured under the same conditions as the product lots found to contain methanol.

Terminated Chemical / undeclared Dibar Nutricional S De Rl De Cv NDC 73009-001-16 D-0645-2021
Class II · Moderate risk

Sodium Chloride 0.9%

Temperature Abuse: Product exposed to temperature outside specified limits.

Terminated Temperature excursion Fresenius Medical Care Holdings, Inc. NDC 46163-0300-10 D-0603-2021
Class II · Moderate risk

Estradiol Transdermal System Delivers 0.0375 mg/day

Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

Terminated Packaging defect Noven Pharmaceuticals Inc NDC 68968-3437-8 D-0337-2021
Class II · Moderate risk

Minivelle (estradiol transdermal system)

Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

Terminated Packaging defect Noven Pharmaceuticals Inc NDC 68968-6675-8 D-0336-2021
Class II · Moderate risk

Oxygen

cGMP deviations

Terminated cGMP deviation Grace Healthcare Medical, Inc D-0355-2021

Recalls by year